Overall, children receiving artemisinin derivatives for treatment of severe malaria had higher median levels of lactate, lactate dehydrogenase, total bilirubin, and parasite biomass (plasma HRP-2) compared to children receiving quinine alone (p<0.05). The gene discussed is HDGFL2; the disease is malaria.